Home › Drug Codes › J Codes › J0737 · CLINDAMYCIN PHOSPHATE IN NACL
Updated July 1st, 2026

CLINDAMYCIN PHOSPHATE IN NACL J Code: J0737

Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J0737, effective October 1, 2026: $2.068 per HCPCS billing unit, down 5.4% from $2.186. From CMS's final file.

?
Medicare Payment Limit ?
$2.186
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
6
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg
HCPCS Added Date July 1, 2023
Manufacturer Baxter Healthcare
Route of Administration Intravenous
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Injection, Solution

About CLINDAMYCIN PHOSPHATE IN NACL

Clindamycin Phosphate IN NACL is a medication aligned to the HCPCS J Code: J0737 for billing, pricing, and reimbursement purposes in the United States. Classified under Antibiotic, it is administered via the intravenous route and manufactured by Baxter Healthcare.

According to CMS Drug Use Information: This medication is used to treat a wide variety of bacterial infections. It works by stopping the growth of bacteria. This medication should not be used to treat meningitis.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 3 of 6 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00338-9545-24 clindamycin phosphate Baxter Healthcare Company 24 300 MG / 50 ML
00338-9549-24 clindamycin phosphate Baxter Healthcare Company 48 600 MG / 50 ML
00338-9553-24 clindamycin phosphate Baxter Healthcare Company 72 900 MG / 50 ML
•••••-••••-•• Log in to view CLINDAMYCIN PHOSPHATE IN NACL
CLINDAMYCIN PHOSPHATE IN NACL
CLINDAMYCIN PHOSPHATE IN NACL
Login to view 3 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

CLINDAMYCIN PHOSPHATE IN NACL Pricing & Reimbursement

J0737 Private Payer Reimbursement
$2.27 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

Clindamycin Phosphate 505(b)(2) Information:

HCPCS Code Manufacturer Active Ingredient HCPCS Description
J0736 Generic Code (Multiple Manufacturers) Clindamycin Phosphate Injection, clindamycin phosphate, 300 mg
J0737 Baxter Healthcare Clindamycin Phosphate Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg

CLINDAMYCIN PHOSPHATE IN NACL CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
JW / JZ modifiers apply

CMS has identified Clindamycin Phosphate IN NACL (J0737) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

CLINDAMYCIN PHOSPHATE IN NACL Medically Unlikely Edits (MUE)

The most billing units of J0737 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 300 mg.

Practitioner Office & Hospital Outpatient
9 units / day
= 2,700 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

CLINDAMYCIN PHOSPHATE IN NACL Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Bone and joint infections Gynecological infections Infections due to susceptible anaerobic bacteria Infections due to susceptible isolates of streptococci, pneumococci and staphylococci Intra-abdominal infections Lower respiratory tract infections Septicemia Skin and skin structure infections
Drug Class
Decreased Sebaceous Gland Activity [PE]Lincosamide Antibacterial [EPC]Lincosamides [CS]Neuromuscular Blockade [PE]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.
Access Full Report →

Frequently Asked Questions

Is there an available Clindamycin Phosphate In Nacl billing and coding guide?
We have not yet identified a manufacturer source of Clindamycin Phosphate In Nacl billing and coding information.
Are there any available Clindamycin Phosphate In Nacl patient assistance programs?
Our team did not identify a source for Clindamycin Phosphate In Nacl patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Clindamycin Phosphate In Nacl prescribing information?
Our team is still working to identify a prescribing information source for CLINDAMYCIN PHOSPHATE IN NACL
Where can I find Clindamycin Phosphate In Nacl side effect information?
Our team has not yet identified a source of side effects information for CLINDAMYCIN PHOSPHATE IN NACL. Please check back in a few weeks.
Does billing CLINDAMYCIN PHOSPHATE IN NACL require JZ/JW wastage modifiers?
CMS has identified CLINDAMYCIN PHOSPHATE IN NACL(J0737) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.

Related Drug Codes

Explore billing, coding, and pricing for drugs related to CLINDAMYCIN PHOSPHATE IN NACL.

J0295Ampicillin-SulbactamInjection, ampicillin sodium/sulbactam sodium, per 1.5 gmMultiple ManufacturersAdded January 1, 1995J0457AZTREONAMInjection, aztreonam, 100 mgMultiple ManufacturersAdded July 1, 2023J0525CEFOTETAN DISODIUMInjection, cefotetan disodium, 10 mgMultiple ManufacturersAdded October 1, 2025J0688CEFAZOLINInjection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mgHikmaAdded January 1, 2024J0689Cefazolin SodiumInjection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mgBaxter HealthcareAdded January 1, 2023J0690CEFAZOLINInjection, cefazolin sodium, 500 mgMultiple ManufacturersAdded January 1, 1982J0694CEFOXITINInjection, cefoxitin sodium, 1 gmMultiple ManufacturersAdded January 1, 1992J0696CEFTRIAXONEInjection, ceftriaxone sodium, per 250 mgMultiple ManufacturersAdded January 1, 1990J0697CEFUROXIME SODIUMInjection, sterile cefuroxime sodium, per 750 mgMultiple ManufacturersAdded January 1, 1990J0713CEFTAZIDIMEInjection, ceftazidime, per 500 mgMultiple ManufacturersAdded January 1, 1996